The findings of the present study indicate that 2 months of NO3− supplementation can alleviate sarcopenia in mice by blunting NMJ deterioration and denervation, enhancing the activity of the Akt/mTOR pathway, and counteracting redox unbalance by increasing GPX content and reducing mitochondrial H2O2 production. This evidence concerns the gene AKT1 and sarcopenia.